companies / createmedicines-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
CREATE Medicines was listed in 8VC's portfolio, recorded 2026-09-30.
verified=2026-05-21 json
| total_raised | 122,000,000122.0M | ○ |
|---|---|---|
| founded | 2020 | |
| hq | Cambridge, USA | |
| industry | unknown | |
| stage | series-b+ |
CREATE Medicines is a drug discovery company using machine learning to design small-molecule therapies for genetically validated targets in oncology and rare disease. Its proprietary generative chemistry platform iterates compound design and synthesis prediction in silico before any wet-lab work begins.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-05-14 | series-b | 122,000,000122.0M | null | ○ |
| investor | src |
|---|---|
| 8VC | ○ |
Netlify, Next.js, React, Webpack
| fact | status | src |
|---|---|---|
| Series B, $122.0M | attributed | ○ |
| Investor 8VC | sourced | WEB |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-30provenance_investor_8vc: unknown → sourced, WEB 2026-09-30 | provenance_investor_8vc | unknown → sourced | WEB 2026-09-30 |
Records begin 2026-09-24. all_changes